Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis.
Harrison SA, Marri SR, Chalasani N, Kohli R, Aronstein W, Thompson GA, Irish W, Miles MV, Xanthakos SA, Lawitz E, Noureddin M, Schiano TD, Siddiqui M, Sanyal A, Neuschwander-Tetri BA, Traber PG. Harrison SA, et al. Aliment Pharmacol Ther. 2016 Dec;44(11-12):1183-1198. doi: 10.1111/apt.13816. Epub 2016 Oct 24. Aliment Pharmacol Ther. 2016. PMID: 27778367 Clinical Trial.
Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis.
Hoofnagle JH, Van Natta ML, Kleiner DE, Clark JM, Kowdley KV, Loomba R, Neuschwander-Tetri BA, Sanyal AJ, Tonascia J; Non-alcoholic Steatohepatitis Clinical Research Network (NASH CRN). Hoofnagle JH, et al. Aliment Pharmacol Ther. 2013 Jul;38(2):134-43. doi: 10.1111/apt.12352. Epub 2013 May 29. Aliment Pharmacol Ther. 2013. PMID: 23718573 Free PMC article. Clinical Trial.
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonascia J, Unalp A, Van Natta M, Clark J, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR; NASH CRN. Sanyal AJ, et al. N Engl J Med. 2010 May 6;362(18):1675-85. doi: 10.1056/NEJMoa0907929. Epub 2010 Apr 28. N Engl J Med. 2010. PMID: 20427778 Free PMC article. Clinical Trial.
Nonalcoholic steatohepatitis.
Neuschwander-Tetri BA. Neuschwander-Tetri BA. Clin Liver Dis. 1998 Feb;2(1):149-73. doi: 10.1016/s1089-3261(05)70369-x. Clin Liver Dis. 1998. PMID: 15560051 Review.
Nonalcoholic steatohepatitis.
Neuschwander-Tetri BA, Bacon BR. Neuschwander-Tetri BA, et al. Med Clin North Am. 1996 Sep;80(5):1147-66. doi: 10.1016/s0025-7125(05)70483-1. Med Clin North Am. 1996. PMID: 8804378 Review.
Fatty liver and nonalcoholic steatohepatitis.
Neuschwander-Tetri BA. Neuschwander-Tetri BA. Clin Cornerstone. 2001;3(6):47-57. doi: 10.1016/s1098-3597(01)90078-x. Clin Cornerstone. 2001. PMID: 11501194 Review.
Oleanolic Acid Improves Gut Atrophy Induced by Parenteral Nutrition.
Jain AK, Wen JX, Blomenkamp KS, Arora S, Blaufuss TA, Rodrigues J, Long JP, Neuschwander-Tetri BA, Teckman JH. Jain AK, et al. JPEN J Parenter Enteral Nutr. 2016 Jan;40(1):67-72. doi: 10.1177/0148607115583536. Epub 2015 Apr 28. JPEN J Parenter Enteral Nutr. 2016. PMID: 25921560
200 results